Literature DB >> 7943276

Endothelins stimulate mitogen-activated protein kinase cascade through either ETA or ETB.

Y Wang1, P M Rose, M L Webb, M J Dunn.   

Abstract

Endothelin (ET) has been shown to activate mitogen-activated protein kinase (MAPK). However, it has been unclear which of the ET receptors is coupled to MAPK activation. In the present study, we conducted experiments to determine which ET receptor is linked to MAPK activation. We found that both human ETA and ETB were coupled to the MAPK cascade in ETA or ETB cDNA-transfected Chinese hamster ovary cells. ET-1 was more potent than ET-3 in the activation of p42 MAPK, induction of MAPK kinase (MAPKK) gel retardation and uptake of [3H]thymidine in ETA-transfected cells, whereas sarafotoxin (S6c) showed no stimulatory effect on the kinases and [3H]thymidine uptake. ET-1, ET-3, and S6c had approximately the same potency to activate p42 MAPK, MAPKK gel retardation, and [3H]thymidine uptake in ETB-transfected cells. These data suggest that 1) ET isopeptides, through either ETA or ETB receptors, induce the MAPK cascade as well as cell proliferation; and 2) the different potencies of ET isopeptides for activation of the MAPK cascade and induction of cell growth are mainly due to their different affinities toward ETA and ETB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943276     DOI: 10.1152/ajpcell.1994.267.4.C1130

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Effect of nitric oxide on mitogen-activated protein kinases in neonatal pulmonary vascular smooth muscle.

Authors:  Scott A Barman
Journal:  Lung       Date:  2005 Sep-Oct       Impact factor: 2.584

Review 2.  Endothelin and heart failure.

Authors:  P Nambi; M Clozel; G Feuerstein
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

3.  Mechanism of endothelin-1 activation of MAP kinases in neonatal pulmonary vascular smooth muscle.

Authors:  Scott A Barman; Mario B Marrero
Journal:  Lung       Date:  2005 Nov-Dec       Impact factor: 2.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.